Voice Disorder
7
0
0
3
Key Insights
Highlights
Success Rate
60% trial completion
Treatment Research
6 treatments under study, led by Emst
Research Leaders
7 sponsors active, led by National Institute of Neurological Disorders and Stroke (NINDS)
Related Conditions
Often studied with 20 related conditions
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
28.6%
2 terminated out of 7 trials
60.0%
-26.6% vs benchmark
0%
0 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (7)
"Effects of EMST and Triflo on Voice Parameters and Vocal Fatigue"
PhoRTE® Therapy Efficacy: In-Person Versus Telehealth
Expiratory Muscle Strength Training and Phonation Resistance Training Exercises For Elderly Patients With Vocal Fold Atrophy
Central Mechanisms in Speech Motor Control Studied With H215O PET
Characteristics of Idiopathic Familial Voice Disorders
Sensory Function in Idiopathic Voice Disorders
Prevention and Treatment of Voice Problems in Teachers
Research Network
Common Treatments
- Emst2
- Voice Hygiene1
- Exuberant Voice Therapy1
- Phorte1
- Triflo1
Active Sponsors
- National Institute of Neurological Disorders and Stroke (NINDS)2
- Emory University1
- Medipol University1
- The University of Hong Kong1
- University of Southern California1
Top Investigators
Emory University
National Institute on Deafness and Other Communication Disorders (NIDCD)
University of Southern California
Medipol University
Related Conditions
- Presbyphonia2
- Spastic Dysphonia2
- Voice Alteration1
- Dysphonia1
- Healthy1